BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20595457)

  • 1. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
    Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
    Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
    Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
    Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.
    Hersh CP; Dahl M; Ly NP; Berkey CS; Nordestgaard BG; Silverman EK
    Thorax; 2004 Oct; 59(10):843-9. PubMed ID: 15454649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Rare
    Ortega VE; Li X; O'Neal WK; Lackey L; Ampleford E; Hawkins GA; Grayeski PJ; Laederach A; Barjaktarevic I; Barr RG; Cooper C; Couper D; Han MK; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Peters SP; Pirozzi C; Rennard SI; Woodruff PG; Hoffman EA; Meyers DA; Bleecker ER;
    Am J Respir Crit Care Med; 2020 Mar; 201(5):540-554. PubMed ID: 31661293
    [No Abstract]   [Full Text] [Related]  

  • 5. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
    Demeo DL; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):114-20. PubMed ID: 17690329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
    Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
    Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.
    North TL; Ben-Shlomo Y; Cooper C; Deary IJ; Gallacher J; Kivimaki M; Kumari M; Martin RM; Pattie A; Sayer AA; Starr JM; Wong A; Kuh D; Rodriguez S; Day IN
    J Med Genet; 2016 Apr; 53(4):280-8. PubMed ID: 26831755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
    Al Ashry HS; Strange C
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.
    Silverman EK
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S341-5. PubMed ID: 27564671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
    Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
    Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A
    Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
    Ghosh AJ; Hobbs BD; Moll M; Saferali A; Boueiz A; Yun JH; Sciurba F; Barwick L; Limper AH; Flaherty K; Criner G; Brown KK; Wise R; Martinez FJ; Lomas D; Castaldi PJ; Carey VJ; DeMeo DL; Cho MH; Silverman EK; Hersh CP;
    Am J Respir Crit Care Med; 2022 Feb; 205(3):313-323. PubMed ID: 34762809
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
    Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
    Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
    Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Abu Rmilah A; Fencl R; Watt K; Krowka M; Wiesner R; Murray D; Nyberg S; Leise M
    Transplantation; 2021 Jul; 105(7):1576-1584. PubMed ID: 32732616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
    Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
    Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.
    Castaldi PJ; DeMeo DL; Kent DM; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Griffith JL; Silverman EK
    Am J Epidemiol; 2009 Oct; 170(8):1005-13. PubMed ID: 19726494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.